PMIM
REGN icon

Prudent Man Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Prudent Man Investment Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-5
Closed -$3.56K – 184
2025
Q3 		$3.56K Hold
5
– – ﹤0.01% 128
2025
Q2 		$3.56K Hold
5
– – ﹤0.01% 128
2025
Q1 		$3.56K Hold
5
– – ﹤0.01% 128
2024
Q4 		$3.56K Buy
+5
New +$4.2K ﹤0.01% 128

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Prudent Man Investment Management's REGN Position: Q4 2025 in Review

Prudent Man Investment Management sold out of Regeneron Pharmaceuticals (REGN) in Q4 2025, closing a stake of 5 shares — an estimated $3.56K sold.

Prudent Man Investment Management first reported a position in REGN in Q4 2024 and held it in 4 quarters. The position peaked at $3.56K in Q3 2025. 1,387 funds tracked by Wall St. Rank hold REGN as of Q4 2025.

  • Prudent Man Investment Management reported no remaining Regeneron Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Prudent Man Investment Management sold 5 Regeneron Pharmaceuticals shares in Q4 2025, an estimated $3.56K.
  • Prudent Man Investment Management first reported a position in Regeneron Pharmaceuticals in Q4 2024 and held it in 4 quarters.
  • Prudent Man Investment Management's Regeneron Pharmaceuticals position peaked at $3.56K in Q3 2025.
  • 1,387 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2025.

Based on Prudent Man Investment Management's 13F filing for Q4 2025, filed 12 Feb 2026.